Physio-structural and immunological characterization of a PLGA 85/15 encapsulated Chlamydia recombinant MOMP nanovaccine candidate
The quest for vaccine development against Chlamydia trachomatis (CT), the leading cause of bacterial sexually transmitted diseases worldwide, has escalated to reduce its occurrence and global economic burden. Recently, nanovaccines have emerged as attractive candidates [...]